Patho-Pharmacological Research of Anti-allergic Natural Products Targeting Antihistamine-Sensitive and -Insensitive Allergic Mechanisms.

[1]  N. Takeda,et al.  Signaling Pathway of Histamine H1 Receptor-Mediated Histamine H1 Receptor Gene Upregulation Induced by Histamine in U-373 MG Cells , 2021, Current issues in molecular biology.

[2]  N. Takeda,et al.  Effects of Syo-seiryu-to and Its Constituent Crude Drugs on Phorbol Ester-Induced Up-Regulation of IL-33 and Histamine H1 Receptor mRNAs in Swiss 3T3 and HeLa Cells , 2021, Allergies.

[3]  N. Takeda,et al.  Identification and characterisation of the anti‐allergic compound from lotus root , 2020 .

[4]  N. Takeda,et al.  Identification of pyrogallol from Awa-tea as an anti-allergic compound that suppresses nasal symptoms and IL-9 gene expression. , 2020, The journal of medical investigation : JMI.

[5]  Dimitris Tousoulis,et al.  The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives , 2018, European cardiology.

[6]  Jonathan R. Brestoff,et al.  Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch , 2017, Cell.

[7]  E. Sanchez,et al.  IL-9: Function, Sources, and Detection. , 2017, Methods in molecular biology.

[8]  H. Mizuguchi,et al.  Protein kinase C-δ signaling regulates glucagon secretion from pancreatic islets. , 2017, The journal of medical investigation : JMI.

[9]  Hanan S. Anbar,et al.  Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats. , 2016, European journal of pharmacology.

[10]  M. Neurath,et al.  IL-9 signaling as key driver of chronic inflammation in mucosal immunity. , 2016, Cytokine & growth factor reviews.

[11]  N. Takeda,et al.  Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats. , 2016, Journal of pharmacological sciences.

[12]  N. Takeda,et al.  Effects of antihistamine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosis induced by controlled cedar pollen challenge in an environmental exposure unit. , 2015, Journal of pharmacological sciences.

[13]  N. Takeda,et al.  Maackiain is a novel antiallergic compound that suppresses transcriptional upregulation of the histamine H1 receptor and interleukin-4 genes , 2015, Pharmacology research & perspectives.

[14]  A. Sugawara,et al.  Role of histamine H3 receptor in glucagon-secreting αTC1.6 cells , 2014, FEBS open bio.

[15]  A. Sugawara,et al.  The expression and function of histamine H3 receptors in pancreatic beta cells , 2014, British journal of pharmacology.

[16]  Andre Pascal Kengne,et al.  Diabetes Mellitus and Inflammation , 2013, Current Diabetes Reports.

[17]  N. Takeda,et al.  Preseasonal prophylactic treatment with antihistamines suppresses IL−5 but not IL-33 mRNA expression in the nasal mucosa of patients with seasonal allergic rhinitis caused by Japanese cedar pollen , 2012, Acta oto-laryngologica.

[18]  Sonia Sharma,et al.  Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex , 2011, Proceedings of the National Academy of Sciences.

[19]  N. Takeda,et al.  Deprivation of anticipated food under scheduled feeding induces c-Fos expression in the caudal part of the arcuate nucleus of hypothalamus through histamine H1 receptors in rats: Potential involvement of E3 subgroup of histaminergic neurons in tuberomammillary nucleus , 2011, Brain Research.

[20]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[21]  J. Lachowicz,et al.  Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan. , 2011, Endocrinology.

[22]  N. Takeda,et al.  Preseasonal prophylactic treatment with antihistamines suppresses nasal symptoms and expression of histamine H₁ receptor mRNA in the nasal mucosa of patients with pollinosis. , 2010, Methods and findings in experimental and clinical pharmacology.

[23]  R. Noelle,et al.  Cellular sources and immune functions of interleukin-9 , 2010, Nature Reviews Immunology.

[24]  J. Holst,et al.  The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action , 2010, Diabetes.

[25]  N. Takeda,et al.  Suplatast Tosilate Inhibits Histamine Signaling by Direct and Indirect Down-Regulation of Histamine H1 Receptor Gene Expression through Suppression of Histidine Decarboxylase and IL-4 Gene Transcriptions1 , 2009, The Journal of Immunology.

[26]  N. Takeda,et al.  Effects of hypergravity on histamine H1 receptor mRNA expression in hypothalamus and brainstem of rats: implications for development of motion sickness , 2009, Acta oto-laryngologica.

[27]  I. Graef,et al.  NFAT signaling and the invention of vertebrates. , 2007, Trends in cell biology.

[28]  D. Macneil,et al.  Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus , 2006, Proceedings of the National Academy of Sciences.

[29]  K. Fujimoto,et al.  Two threonine residues and two serine residues in the second and third intracellular loops are both involved in histamine H1 receptor downregulation , 2004, FEBS letters.

[30]  K. Fujimoto,et al.  Identification of amino acid residues responsible for agonist-induced down-regulation of histamine H(1) receptors. , 2004, Journal of pharmacological sciences.

[31]  K. Hirakawa,et al.  Suppression of the Th2 Pathway by Suplatast Tosilate in Patients with Perennial Nasal Allergies , 2002, American journal of rhinology.

[32]  Y. Horio,et al.  Expression cloning of a cDNA encoding the bovine histamine H1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Kubo,et al.  Neurochemical mechanisms of motion sickness. , 1989, American journal of otolaryngology.

[34]  P. Dandona,et al.  Plasma histamine concentrations are elevated in patients with diabetes mellitus and peripheral vascular disease. , 1989, Metabolism: clinical and experimental.

[35]  T. Gardner,et al.  Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes. , 1989, Archives of ophthalmology.

[36]  H. Yoshimatsu,et al.  Modulation of neuronal histamine in control of food intake , 1988, Physiology & Behavior.

[37]  J. Kern,et al.  Changes in plasma histamine concentration in the streptozotocin-diabetic rat. , 1985, Experimental and molecular pathology.